TY - JOUR
T1 - FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia
AU - Lee, Benjamin H.
AU - Tothova, Zuzana
AU - Levine, Ross L.
AU - Anderson, Kristina
AU - Buza-Vidas, Natalija
AU - Cullen, Dana E.
AU - McDowell, Elizabeth P.
AU - Adelsperger, Jennifer
AU - Frhling, Stefan
AU - Huntly, Brian J. P.
AU - Beran, Miloslav
AU - Jacobsen, Sten Eirik W
AU - Gilliland, D. Gary
PY - 2007
Y1 - 2007
N2 - Despite their known transforming properties, the effects of leukemogenic FLT3-ITD mutations on hematopoietic stem and multipotent progenitor cells and on hematopoietic differentiation are not well understood. We report a mouse model harboring an ITD in the murine Flt3 locus that develops myeloproliferative disease resembling CMML and further identified FLT3-ITD mutations in a subset of human CMML. These findings correlated with an increase in number, cell cycling, and survival of multipotent stem and progenitor cells in an ITD dose-dependent manner in animals that exhibited alterations within their myeloid progenitor compartments and a block in normal B cell development. This model provides insights into the consequences of constitutive signaling by an oncogenic tyrosine kinase on hematopoietic progenitor quiescence, function, and cell fate.
AB - Despite their known transforming properties, the effects of leukemogenic FLT3-ITD mutations on hematopoietic stem and multipotent progenitor cells and on hematopoietic differentiation are not well understood. We report a mouse model harboring an ITD in the murine Flt3 locus that develops myeloproliferative disease resembling CMML and further identified FLT3-ITD mutations in a subset of human CMML. These findings correlated with an increase in number, cell cycling, and survival of multipotent stem and progenitor cells in an ITD dose-dependent manner in animals that exhibited alterations within their myeloid progenitor compartments and a block in normal B cell development. This model provides insights into the consequences of constitutive signaling by an oncogenic tyrosine kinase on hematopoietic progenitor quiescence, function, and cell fate.
U2 - 10.1016/j.ccr.2007.08.031
DO - 10.1016/j.ccr.2007.08.031
M3 - Article
C2 - 17936561
SN - 1878-3686
VL - 12
SP - 367
EP - 380
JO - Cancer Cell
JF - Cancer Cell
IS - 4
ER -